Oncternal Therapeutics Inc Forecast, price target & analysts
$0.53
0.00%
Nasdaq, Wed, Sep 16 2026.
Oncternal Therapeutics Inc Target price 2026 - Analyst rating & recommendation
Powered by
Oncternal Therapeutics Inc Classifications & Recommendation
Hold
50%
Sell
50%
Oncternal Therapeutics Inc Price Target
| Target Price | $2.04 |
| Price | $0.53 |
| Potential |
287.39%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Oncternal Therapeutics Inc 2027 .
The average Oncternal Therapeutics Inc target price is $2.04.
This is
287.39%
register free of charge
$2.10
298.78%
register free of charge
$2.02
283.59%
register free of charge
|
|
| A rating was issued by 6 analysts: 0 Analysts recommend Oncternal Therapeutics Inc to buy, 3 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Oncternal Therapeutics Inc stock has an average upside potential 2027 of
287.39%
register free of charge
|
Current Oncternal Therapeutics Inc Upgrades & Downgrades
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Brookline Capital |
Locked
➜
Locked
|
Locked | Sep 12 2024 |
| Northland Capital Markets |
Locked
➜
Locked
|
Locked | Sep 12 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Brookline Capital:
Locked
➜
Locked
|
Sep 12 2024 |
|
Locked
Northland Capital Markets:
Locked
➜
Locked
|
Sep 12 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
